Neurological and Cerebrospinal Fluid Accumulation Effects of Non-Cobalt Metal Ions from Joint Implants: Cognition, Peripheral Neuropathy, and Movement Disorders

Abstract

Background:
Joint arthroplasty remains a cornerstone of orthopedic surgery, restoring mobility and alleviating pain for millions of patients worldwide. With advances in implant longevity and expanding use among younger, more active individuals, attention has turned toward the long-term systemic effects of implant wear and corrosion. While cobalt and chromium toxicity from metal-on-metal designs is well documented, emerging data suggest that non-cobalt metal ions—particularly titanium (Ti), niobium (Nb), zirconium (Zr), and vanadium (V)—may also accumulate in systemic circulation and cerebrospinal fluid (CSF), raising concern for potential neurologic sequelae.

Purpose:
This review synthesizes current mechanistic and clinical evidence linking non-cobalt metal ion exposure from joint implants to neurologic outcomes, with the goal of informing both orthopaedic and neurology practice.

Methods:
Recent mechanistic, cohort, and case-based literature was examined to characterize (1) pathways of ion release and systemic accumulation, (2) mechanisms of neural barrier penetration and neurotoxicity, (3) observed neurologic manifestations, and (4) clinical and surveillance implications. Key studies include cross-sectional analyses of blood and CSF metal levels, case reports of neurologic dysfunction, and translational work on metal-induced oxidative and inflammatory injury.

Results:
Non-cobalt metal ions are released through mechanical wear, fretting, and electrochemical corrosion, subsequently entering systemic circulation and crossing neural barriers. Elevated Ti, Nb, and Zr concentrations have been documented in CSF of arthroplasty patients compared with controls, confirming central nervous system exposure. Mechanistic data implicate oxidative stress, mitochondrial dysfunction, and glial activation in metal-related neurotoxicity. Clinical observations include cognitive decline, peripheral neuropathy, and movement disorders, although large-scale, longitudinal evidence remains limited. No randomized controlled trials have evaluated neurologic endpoints, and standardized surveillance protocols are lacking.

Conclusions:
While modern joint arthroplasty is highly effective, accumulating evidence supports the biologic plausibility and emerging reality of neurologic effects associated with systemic accumulation of non-cobalt metal ions. Patients with high activity levels, renal impairment, or pre-existing neurologic conditions may be particularly vulnerable. Future research should focus on prospective cohorts linking quantified metal exposure to validated neurologic outcomes, biomarker development, and implant innovations that minimize ion release. Integration of neurologic screening into long-term arthroplasty follow-up may be essential as implant lifespans continue to extend.